RNActive® Rabies Vaccine (CV7201) in Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

101

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

February 8, 2018

Study Completion Date

February 8, 2018

Conditions

Rabies

Interventions

BIOLOGICAL

CV7201 mRNA

CV7201 is composed of 1 RNActive® mRNA that encodes the rabies virus glycoprotein.

Trial Locations (1)

Abteilung für Infektions- und Tropenmedizin der Ludwig-Maximilians-Universität, Munich